Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 22, 2021

SELL
$13.43 - $19.16 $13,430 - $19,160
-1,000 Closed
0 $0
Q1 2021

Apr 12, 2021

BUY
$15.82 - $22.11 $15,820 - $22,110
1,000 New
1,000 $16,000
Q4 2020

Feb 11, 2021

SELL
$7.91 - $22.95 $23,730 - $68,850
-3,000 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$4.67 - $8.95 $14,010 - $26,849
3,000 New
3,000 $25,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $547M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.